Mei Peng
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
- Molecular Biology top 10%
- Metabolism, Diabetes, and Cancer
- Gut microbiota and health
- Epigenetics and DNA Methylation
Papers in
-
- Pregnancy and preeclampsia studies 9
Mei Peng
85 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 110
- Cancer Research 264
- Molecular Biology 698
- Oncology 250
- Obstetrics and Gynecology 60
- Biochemistry 33
Countries citing papers authored by Mei Peng
This map shows the geographic impact of Mei Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei Peng more than expected).
Fields of papers citing papers by Mei Peng
This network shows the impact of papers produced by Mei Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei Peng. The network helps show where Mei Peng may publish in the future.
Co-authors
The 25 scholars most cited alongside Mei Peng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 5 | |
| 8 | 2024 | 10 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 16 | |
| 12 | 2022 | 2 | |
| 13 | 2022 | 66 | |
| 14 | 2022 | 1 | |
| 15 | 2021 | 41 | |
| 16 | 2021 | 12 | |
| 17 | 2020 | 25 | |
| 18 | 2020 | 3 | |
| 19 | 2019 | 19 | |
| 20 | 2015 | 21 |
About Mei Peng
Mei Peng is a scholar working on Obstetrics and Gynecology, Biochemistry, Cancer Research, Parasitology and Toxicology, having authored 94 papers that have together received 1.5k indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (12 papers), Pregnancy and preeclampsia studies (9 papers), Cancer, Hypoxia, and Metabolism (6 papers), Epigenetics and DNA Methylation (6 papers), Cancer-related Molecular Pathways (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Parasites and Host Interactions (4 papers) and Birth, Development, and Health (4 papers). The work is most often cited by research in Cancer Research (264 citations), Molecular Biology (698 citations), Oncology (250 citations), Obstetrics and Gynecology (60 citations) and Biochemistry (33 citations). Mei Peng has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Xiaoping Yang, Ting Tao, Yanjun Huang, Qiongli Su, Jun Deng, Sichun Zhou, Kwame Oteng Darko, Caimei He, Di Xiao and Xiaojun Tao. Their work appears in journals such as International Journal of Molecular Sciences, Journal of Ethnopharmacology, PLoS ONE, International Journal of Biological Sciences and Free Radical Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.